| Positioning and reversible suppression of CCR7+ dendritic cells in perivascular tumor niches shape cancer immunity | Immunity |  | | 2026 | 30 | 5 |
|
| Circadian tumor infiltration and function of CD8+ T cells dictate immunotherapy efficacy | Cell |  | | 2024 | 1,009 | 417 |
|
| A neutrophil response linked to tumor control in immunotherapy | Cell |  | | 2023 | 94 | 130 |
|
| Dendritic cells direct circadian anti-tumour immune responses | Nature |  | | 2023 | 806 | 231 |
|
| CXCL9:SPP1 macrophage polarity identifies a network of cellular programs that control human cancers | Science |  | | 2023 | 807 | 2 |
|
| Dual TLR9 and PD-L1 targeting unleashes dendritic cells to induce durable antitumor immunity | Journal for immunotherapy of cancer |  | | 2023 | 49 | 29 |
|
| Macrophage-Targeted Therapy Unlocks Antitumoral Cross-talk between IFNg-Secreting Lymphocytes and IL12-Producing Dendritic Cells | Cancer immunology research |  | | 2022 | 201 | 65 |
|
| Resident Kupffer cells and neutrophils drive liver toxicity in cancer immunotherapy | Science Immunology |  | | 2021 | 474 | 1,019 |
|
| Diagnostic challenges and successful organ-preserving therapy in a case of secretory carcinoma of minor salivary glands | Cancer Reports |  | | 2021 | 199 | 214 |
|
| Tumor-infiltrating dendritic cell states are conserved across solid human cancers | Journal of Experimental Medicine |  | | 2021 | 301 | 529 |
|